196 related articles for article (PubMed ID: 18347507)
1. Diagnosing endometrial hyperplasia: why is it so difficult to agree?
Allison KH; Reed SD; Voigt LF; Jordan CD; Newton KM; Garcia RL
Am J Surg Pathol; 2008 May; 32(5):691-8. PubMed ID: 18347507
[TBL] [Abstract][Full Text] [Related]
2. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma.
Kendall BS; Ronnett BM; Isacson C; Cho KR; Hedrick L; Diener-West M; Kurman RJ
Am J Surg Pathol; 1998 Aug; 22(8):1012-9. PubMed ID: 9706982
[TBL] [Abstract][Full Text] [Related]
4. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens.
Bergeron C; Nogales FF; Masseroli M; Abeler V; Duvillard P; Müller-Holzner E; Pickartz H; Wells M
Am J Surg Pathol; 1999 Sep; 23(9):1102-8. PubMed ID: 10478671
[TBL] [Abstract][Full Text] [Related]
5. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
6. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
[TBL] [Abstract][Full Text] [Related]
7. International Internet-based assessment of observer variability for diagnostically challenging endometrial biopsies.
Marotti JD; Glatz K; Parkash V; Hecht JL
Arch Pathol Lab Med; 2011 Apr; 135(4):464-70. PubMed ID: 21466363
[TBL] [Abstract][Full Text] [Related]
8. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
[TBL] [Abstract][Full Text] [Related]
9. Inter-observer reproducibility of endometrial cytology by the Osaki Study Group method: utilising the Becton Dickinson SurePath
Norimatsu Y; Yamaguchi T; Taira T; Abe H; Sakamoto H; Takenaka M; Yanoh K; Yoshinobu M; Irino S; Hirai Y; Kobayashi TK
Cytopathology; 2016 Dec; 27(6):472-478. PubMed ID: 27109167
[TBL] [Abstract][Full Text] [Related]
10. Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Mentrikoski MJ; Shah AA; Hanley KZ; Atkins KA
Am J Clin Pathol; 2012 Oct; 138(4):524-34. PubMed ID: 23010707
[TBL] [Abstract][Full Text] [Related]
11. Endometrial Intraepithelial Neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 World Health Organization classification for endometrial hyperplasia.
Li XC; Song WJ
Asian Pac J Cancer Prev; 2013; 14(10):5935-9. PubMed ID: 24289604
[TBL] [Abstract][Full Text] [Related]
12. Study on the morphology and reproducibility of the diagnosis of endometrial lesions utilizing liquid-based cytology.
Papaefthimiou M; Symiakaki H; Mentzelopoulou P; Tsiveleka A; Kyroudes A; Voulgaris Z; Tzonou A; Karakitsos P
Cancer; 2005 Apr; 105(2):56-64. PubMed ID: 15751019
[TBL] [Abstract][Full Text] [Related]
13. Endometrial hyperplasia/adenocarcinoma. a conventional approach.
Mazur MT
Ann Diagn Pathol; 2005 Jun; 9(3):174-81. PubMed ID: 15944963
[TBL] [Abstract][Full Text] [Related]
14. [Early diagnosis of adenocarcinoma by endometrial cytologic samples].
Zarcone R; D'Apuzzo N; Sansone A; Vullo G; Monarca M
Minerva Ginecol; 1997 Sep; 49(9):421-3. PubMed ID: 9446078
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia.
Skov BG; Broholm H; Engel U; Franzmann MB; Nielsen AL; Lauritzen AF; Skov T
Int J Gynecol Pathol; 1997 Jan; 16(1):33-7. PubMed ID: 8986530
[TBL] [Abstract][Full Text] [Related]
16. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
17. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
Horn LC; Bilek K; Schnurrbusch U
Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
[TBL] [Abstract][Full Text] [Related]
18. Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia.
Morrison ML; McCluggage WG; Price GJ; Diamond J; Sheeran MR; Mulholland KM; Walsh MY; Montironi R; Bartels PH; Thompson D; Hamilton PW
J Pathol; 2002 Jul; 197(3):403-14. PubMed ID: 12115888
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change.
Gurda GT; Baras AS; Kurman RJ
Int J Gynecol Pathol; 2014 Mar; 33(2):114-9. PubMed ID: 24487464
[TBL] [Abstract][Full Text] [Related]
20. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
McKenney JK; Longacre TA
Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
